Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research, Inc. is a Canadian specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units: the Topical Products and Technology (TPT) Group (formerly the Pain Group) and the Immunology Group.
Price: $7.60 | Change: $-0.22 | %Change: -2.81%
Volume: 21,368 | Day High/Low: 7.90/7.56 | 52 Week High/Low: 8.33/1.66
View modes: 
3 stars

Zacks

Zacks Small Cap Research Jason Napodano  rate and reply
5 stars

RE:RE:RE:Its possible

http://scr.zacks.com/files/Nov-12-2014_T-NRI_Napodano_v002_v6t886.pdf ps. how quickly sp target has to be revised? :) cheers, dave.  rate and reply
3 stars

RE:RE:RE:Its possible

Can you share the article pleasE?  rate and reply
2.5 stars

RE:RE:Its possible

Lots of continuing upside. Zacks is now forecasting peak sales of WF10 in the US of $800 million US. Updated clinical results are going to push Nuvo above $20.  rate and reply
3 stars

RE:Its possible

in time, anything is possible. parabolic moves up or down, usually mean in short term an opposite move will happen most if not all the time.....take care selling near lows or in case of NRI, take care...read more
3.5 stars

Its possible

Concord was $7 this time last year. Its now $41. All that is needed is a good asset base and on target execution.  rate and reply
3 stars

RE:RE:You pumpers (ronz, rock, etc) are pathetic...

thing is, you lose, profit of a stock in your own time, during a life cycle of the company as well as its share price. cheers, dave.  rate and reply
3.5 stars

RE:RE:RE:Details of Endo US marketing rights from Novartis

I'm one of those long time investors. As Ronz, I've sold and bought but obviously I'm not as astute as him. Although I take what he wrote with a grain of salt. This is not the type of stock that is...read more
3.5 stars

RE:You pumpers (ronz, rock, etc) are pathetic...

Not everybody held onto their stock when the company provided ample warning that the consolidation was looming, so if you held onto your stock through that, you only have yourself to blame. Maybe the...read more
2.5 stars

You pumpers (ronz, rock, etc) are pathetic...

At $7.00, that is 10.7 CENTS pre-consolidation.  wow, how frickin' exciting is that.  too da moon!!!!  rate and reply
2.5 stars

RE:RE:RE:RE:RE:RE:Pennsaid2 and Voltaren Gel

"Alas, poor Yorick! I knew him, Horatio; a fellow of infinite jest, of most excellent fancy;...." Plenty of old timers still lurk but have little to say except that hope springs eternal. Regards pdm  rate and reply
3.5 stars

RE:RE:RE:RE:RE:Pennsaid2 and Voltaren Gel

Hi JackieC and others. Not unlike yourself, last visit 4 years ago. And that was a momentary blip since the Peter B. days. Hey Cheif, Wolf, Krupa, BTF {and Umra you lurkin' bastid} "Move On" say some;...read more
2 stars

RE:Details of Endo US marketing rights from Novartis

Let's apply the Voltaren Gel metrics to what WF10 might generate should Nuvo license its marketing rights much as Norvartis with Endo......also in the US only. Endo paid $145 million US for a 5 year...read more
2.5 stars

RE:RE:RE:Dobranowski unloaded 3,846 shares

You act like its millions of shares he's dumped on the market.... It's only 3846 shares! Give it a rest already. They are shareholders just like you and I, and they are entitled to buy, or sell stock...read more
2 stars

RE:RE:RE:Details of Endo US marketing rights from Novartis

Gimme a break. An insider? Check my posting spoor. Yeah right. Insider sells a few thousand rights. Meaningful ? Yeah right. If after 15 years invested here and you have uncertainties relative to your...read more
2 stars

RE:RE:Dobranowski unloaded 3,846 shares

These are a few rights being sold which is how they get paid. Its irrelevant In your opinion. I don't know anyone that would leave money on the table particularly if a deal was close at hand. That...read more
3.5 stars

RE:RE:Details of Endo US marketing rights from Novartis

TheRock07 wrote: Of course, Nuvo received an apparently lucrative manufacturing deal from Horizon as part of the P2 deal i think this clown has just tipped his hat that he is an insider, as many...read more
3 stars

RE:RE:Details of Endo US marketing rights from Novartis

Of course, Nuvo received an apparently lucrative manufacturing deal from Horizon as part of the P2 deal And you know this how? There is nothing in the supply agreement that provides any light on...read more
2 stars

RE:Details of Endo US marketing rights from Novartis

As can be deduced, Endo paid at least $145 million for the 5 year marketing rights BY Prescription of Voltaren Gel in the US. Voltaren Gel was estimated at that time to have peak sales in the $250 m...read more
1 star

Details of Endo US marketing rights from Novartis

Novartis AG On March 4, 2008, we entered into a license and supply agreement (referred to as the Voltaren ® Gel Agreement) with and among Novartis AG and Novartis Consumer Health, Inc., (referred to...read more